Tag | Content |
---|
EnhancerAtlas ID | HS017-21265 |
Organism | Homo sapiens |
Tissue/cell | CD14+_monocyte |
Coordinate | chr21:35352680-35353550 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
MYCN | MA0104.4 | chr21:35352743-35352755 | GACCACGTGGCC | + | 6.52 | MYCN | MA0104.4 | chr21:35352743-35352755 | GACCACGTGGCC | - | 6.52 | NR2C2 | MA0504.1 | chr21:35352721-35352736 | AGGGTTCAGAGGTCA | + | 6.64 | Rxra | MA0512.2 | chr21:35352722-35352736 | GGGTTCAGAGGTCA | + | 6.3 | Sox6 | MA0515.1 | chr21:35353146-35353156 | AAAACAATGG | - | 6.02 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_56093 | chr21:35352866-35354298 | u87 | SE_67857 | chr21:35352866-35354298 | u87 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr21 | 35352682 | 35352885 | chr21 | 35352906 | 35353192 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH21I033980 | chr21 | 35352721 | 35352870 |
|
Enhancer Sequence | TCATTTAGGT ATTGTTACGG CTGCTTCCAC ACTACAGCAG CAGGGTTCAG AGGTCATGGC 60 AGAGACCACG TGGCCCACAA AGGTGAATGT ACTTCCCTTT GTAGAAGCTG TTTGCCAAAC 120 TCTTGGCTAG CAGAGTGAGT CATGAGAGAA GAGAGAAGTG CATGGACTGA GGTCTGTCCA 180 GGGCCTGTCA AGAGCCAGTA ACCGTTGCTG TGCGTCAAGG ATGCCAAGAT GGTGCCTGCT 240 CCATGAGCAA CAAAGCCCAG GGGCCCAGCA AGCCAAGGCT GCTTGCCTCT TCCCCTGGGG 300 CCAGCTGTGC ATCTTGTGGA TGGCTGAAGT TGAGCAACCC ATAACAGGCT CCTGACCCAC 360 TGTGAGATGG TGGCATGTGA AAGGACCAGC ATCCAACAGT CTTGCCCTTA CTATATTAGT 420 AATTTCCTGG GGCTACAGGA GCTATTTACT ACAAACTGAG TGACTTAAAA CAATGGAAAT 480 GGATTCTCTC GCAGTTCTAG AGGGTATTAT TCTTTCAATC AATCAAGGTG ACAGCAGGGC 540 CATGCTCCCA AAGACAGCTC TAGGAAAAGC TCCTGGTTTC TAGCGGCTGC CTGCACTCCT 600 TGGCATTCCT TGGCTTACAG CTGCATCATT CCAGTCTCTG CTTCGGTCAC CACGTGCCTT 660 CATCCCTGGG TCGCTTCCAT GTCTCTATGT CCAAATGTCG CTCTTCTTAT AAGGATGTTA 720 GTCATTGGAT CAGGGCCCAC CCTAATCTGG TATGACTTCA TATTAATGTG ATTGCATTGA 780 TAAAGACGCT GTTTCCAAAT AAAGCCATCG TCACACGTAT GGGGACTAGG ACTTCAACAT 840 ATCTTTTTGA GGGACAAAAT TCTACTCACT 870
|